Vitamin E modulation of hepatic focal lesion growth in mice

Toxicology and Applied Pharmacology

Volumn 143, Issue 2, 1997, Pages 380-387

  Kolaja, Kyle L ^a   Klaunig, James E ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; DIELDRIN; DIETHYLNITROSAMINE; PHENOBARBITAL;

ALPHA TOCOPHEROL DEFICIENCY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; LIVER CARCINOGENESIS; LIVER FOCAL NODULAR HYPERPLASIA; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; ORGAN GROWTH;

EID: 0030972418     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.8089     Document Type: Article

References (41)

1. Bachowski S., Baker T. K., Stevenson D. E., Walborg E. F. Jr., Klaunig J. E. The potential role of oxidative stress in nongenotoxic hepatocarcinogenesis in the mouse liver. Prog. Clin. Biol. Res. 391:1995;385-396.
2. Borek C. Free-radical processed in multistage carcinogenesis. Free Radical Res. Commun. 12-13:1991;745-750.
3. Bursch W., Taper H. S., Lauer B., Schulte-Hermann R. Quantitative histological and histochemical studies on the occurrence and stages of controlled cell death (apoptosis) during regression of rat liver hyperplasia. Virchows Arch. Cell Pathol. 50:1985;153-166.
4. Bursch W. B., Lauer B., Timmermann-Trosenier I., Barthel G., Schuppler J., Schulte-Hermann R. Controlled death (apoptosis) of normal and preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis. 5:1984;453-458.
5. Buttke T. M., Sandstrom P. A. Oxidative stress as a mediator of apoptosis. Immunol. Today. 15:1994;7-10.
6. Cerrutti P. A., Trump B. F. Inflammation and oxidative stress in carcinogenesis. Cancer Lett. 3:1991;1-7.
7. Clayson D. B., Mehta R., Iverson F. Oxidative DNA damage - The effects of certain genotoxic and operationally non-genotoxic carcinogens. Mutat. Res. 317:1994;25-42.
8. Crawford D. Oxidant stress induces the protooncogenes c-fos and c-myc in mouse epidermal cells. Bull. Cancer. 77:1990;501-502.
9. 3. Carcinogenesis. 11:1990;2245-2251.
10. Foulds L. The experimental study of tumor progression: A review. Cancer Res. 14:1954;327-339.
11. Gad S., Weil C. S. Statistics and Experimental Design for Toxicologists. 1986;Telford Press, New Jersey.
12. Gerrisch K. E., Gensler H. L. Prevention of photocarcinogenesis by dietary vitamin E. Nutrit. Cancer. 19:1993;125-133.
13. Glauert H. P., Beaty M., Clark T., Greenwell W., Tatum V., Cehn L., Borges T., Clark T., Srinvivasan S. R., Chow C. Effect of dietary vitamin E on the development of altered hepatic foci and hepatic tumors induced by the peroxisome proliferator ciprofibrate. J. Cancer Res. Clin. Oncol. 116:1990;351-356.
14. 2+. Proc. Natl. Acad. Sci. USA. 86:1989;6758-6762.
15. Helson L., Verma M., Helson C. Vitamin E and human neuroblastoma. Modulation and Mediation of Cancer by Vitamins. 1983;Karger. p. 1-12.
16. Hirose M., Masuda A., Fukushima S., Ito N. Effects of subsequent antioxidant treatment on 7,12-dimethylbenz[a]anthracene-intiatied carcinogenesis of the mammary gland, ear, and forestomach in Sprague-Dawley rats. Carcinogenesis. 9:1988;101-104.
17. Ip C. Attenuation of the anticarcinogenic action of selenium by vitamin E deficiency. Cancer Lett. 25:1985;325-331.
18. Kato M., Popp J., Conolly R., Cattley R. Relationship between hepatocyte necrosis, proliferation, and initiation induced by dietylnitrosamine in the male F344 rat. Fundam. Appl. Toxicol. 20:1993;155-162.
19. Klaunig J. E., Bachowski S., Ketcham C. A., Isenberg J. S., Kolaja K. L., Baker T. K., Walborg E. F. Jr., Stevenson D. E. Oxidative stress in nongenotoxic carcinogenesis. Toxicol. Lett. 82/83:1995;683-691.
20. Klaunig J. E. Selective induction of DNA synthesis in mouse preneoplastic and neoplastic hepatic lesions after exposure to phenobarbital. Environ. Health Perspect. 101:1993;235-249.
21. Kolaja K. L., Stevenson D. E., Walborg E. F. Jr., Klaunig J. E. Dose-dependence of phenobarbital promotion of preneoplastic hepatic lesions in F344 rats and B6C3F1 mice: Effects on DNA synthesis and apoptosis. Carcinogenesis. 17:1996a;947-954.
22. Kolaja K. L., Stevenson D. E., Walborg E. F. Jr., Klaunig J. E. Seletive dieldrin promotion of hepatic focal lesions in mice. Carcinogenesis. 17:1996b;1243-1250.
23. Maki A. Role of [Ca2+]i in induction of c-fos, c-jun, and c-myc mRNA in rat PTE after oxidative stress. FASEB. 6:1992;919-924.
24. Mitchell R. E. J., McCann R. Vitamin E is a complete tumor promoter in mouse skin. Carcinogenesis. 14:1993;659-662.
25. Mizumota Y., Nakae D., Yoshiji H., Andoh N., Horiguchi K., Endoh T., Kobayashi E., Tsujuchi T., Shimoji N., Denda A., Tsujii T., Nagao M., Wakabayashi K., Konishi Y. Inhibitory effects of 2-O-octadeclascorbic acid and other vitamin C and E derivatives on the induction of enzyme-altered putative preneoplastic lesions in the livers of rats fed a choline-deficient, L-amino acid-defined diet. Carcinogenesis. 15:1994;241-246.
26. Ngah W. Z. W., Zanariah J., San M. M., Marzuki A., Top G. M., Shamaan N. A., Kadir K. A. Effect of tocotrienols on hepatocarcinogenesis induced by 2-acetylaminofluorene in rats. Am. J. Clin. Nutr. 53:1991;1076S-1081S.
27. Odeleyle O. E., Eskelson C. D., Mufti S. J., Watson R. R. Vitamin E protection against nitrosamine-induced esophageal tumor incidence in mice immunocompromised by retroviral infection. Carcinogenesis. 13:1992;1811-1816.
28. Pahl H. L., Baeuerle P. A. Oxygen and the control of gene expression. Bioassays. 16:1994;497-502.
29. Peterson F. J., Lindemann N. J., Duquette P. H., Holtzman J. L. Potentiation of acute acetaminophen lethality by selenium and vitamin E deficiency in mice. J. Nutr. 122:1992;74-81.
30. Pitot H. C. Altered hepatic foci: Their role in murine hepatocarcinogenesis. Annu. Rev. Pharmacol. Toxicol. 30:1990;465-500.
31. Pugh T. D., King J. H., Koen H., Nychka D., Chover J., Wahba G., He Y., Goldfarb S. Reliable stereological method for estimating the number of microscopic hepatocellular foci from their transections. Cancer Res. 43:1983;1261-1268.
32. Ruch R. J., Klaunig J. E. Inhibition of mouse hepatocyte intercellular communication by paraquat generated oxygen free radicals. Toxicol. Appl. Pharmacol. 94:1988;427-436.
33. Schulte-Hermann R. S. Tumor promotion in the liver. Arch. Toxicol. 57:1987;147-158.
34. Schulte-Hermann R., Timmermann-Trosnier I., Barthel G., Bursch W. DNA synthesis, apoptosis, and phenotypic expression as a determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res. 50:1990;5127-5135.
35. Sies H. Oxidative stress: Introduction. Oxidative Stress: Oxidants and Antioxidants. 1991;Academic Press, San Diego. p. 15-22.
36. Stinchcombe S., Buchmann A., Bock K. W., Scwarz M. Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumor promotion in rat liver. Carcinogenesis. 16:1995;1271-1275.
37. Sun Y. Free radicals, antioxidant enzymes, and carcinogenesis. Free Radicals Biol. Med. 8:1990;201-209.
38. Thompson H. Effects of deficiencies of selenium and vitamin E alone or in combination on the induction of mammary carcinogenesis by 1-methyl-1-nitrosurea. Carcinogenesis. 12:1991;2175-2179.
39. Toth B., Patil K. Enhancing effects of vitamin E on murine intestinal tumorogenesis by 1,2 diemethylhydrazine dihydrochloride. J. Natl. Cancer Inst. 70:1983;1107-1111.
40. Trush M. A., Kensler T. W. An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Radicals Biol. Med. 10:1991;201-209.
41. Ward J. M. Morphology of hepatocellular neoplasms in B6C3F1 mice. Cancer Lett. 9:1980;319-325.